Turk Ilac ve Serum Sanayi AS
Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. The company was founded in 2010 and is headquartered in Ankara, Turkey.
Turk Ilac ve Serum Sanayi AS (TRILC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.023x
Based on the latest financial reports, Turk Ilac ve Serum Sanayi AS (TRILC) has a cash flow conversion efficiency ratio of 0.023x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL44.50 Million) by net assets (TL1.91 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Turk Ilac ve Serum Sanayi AS - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Turk Ilac ve Serum Sanayi AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Turk Ilac ve Serum Sanayi AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Turk Ilac ve Serum Sanayi AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Actinium Pharmaceuticals Inc
NYSE MKT:ATNM
|
-0.459x |
|
Mermaid Maritime Public Company Limited
PINK:MMMPF
|
-0.015x |
|
Gulshan Polyols Limited
NSE:GULPOLY
|
-0.040x |
|
Advice It Infinite Pcl
BK:ADVICE
|
0.024x |
|
Madison County Financial Inc
PINK:MCBK
|
0.004x |
|
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
|
-0.314x |
|
Harmony Electronics
TWO:8182
|
-0.019x |
|
Tamul Multimedia Co. Ltd
KQ:093640
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Turk Ilac ve Serum Sanayi AS (2018–2024)
The table below shows the annual cash flow conversion efficiency of Turk Ilac ve Serum Sanayi AS from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL1.92 Billion | TL-378.48 Million | -0.197x | -185.55% |
| 2023-12-31 | TL1.78 Billion | TL408.19 Million | 0.230x | +1193.03% |
| 2022-12-31 | TL564.69 Million | TL-11.88 Million | -0.021x | +90.49% |
| 2021-12-31 | TL324.08 Million | TL-71.67 Million | -0.221x | -198.67% |
| 2020-12-31 | TL148.13 Million | TL33.20 Million | 0.224x | +9.86% |
| 2019-12-31 | TL65.28 Million | TL13.32 Million | 0.204x | -66.57% |
| 2018-12-31 | TL62.47 Million | TL38.13 Million | 0.610x | -- |